English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT04458831 /

IONA OBS16577

A Prospective, Non-Interventional, Multinational, Observational Study With Isatuximab In Patients With Relapsed And/Or Refractory Multiple Myeloma (RRMM)

DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Accepting Patients
Location:
Freehold, NJ, Howell, NJ, Little Silver, NJ
For More information: